Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 6, 2014
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetesGiovanni Targher, Filippo Valbusa, Stafano Bonapace, et al.
Diabetes, Obesity & Metabolism|June 23, 2021
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trialJuan P Frias, Enzo Bonora, Luis Nevárez Ruiz, et al.
Diabetes/Metabolism Research and Reviews|October 9, 2007
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR databaseGiorgio Sesti, Francesco Andreozzi, Riccardo C Bonadonna, et al.
Diabetes Care|January 5, 2021
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)Juan P Frias, Enzo Bonora, Luis Nevarez Ruiz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 17, 2021
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition ProjectSilvia Pasquini, Elisabetta Rinaldi, Giuliana Da Prato, et al.
BMJ Open Diabetes Research & Care|May 2, 2015
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetesGiacomo Zoppini, Anna Galletti, Giovanni Targher, et al.
Diabetes, Obesity & Metabolism|March 28, 2018
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetesEmanuela Orsi, Anna Solini, Enzo Bonora, et al.
Diabetologia|July 23, 2018
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre studyGiuseppe Penno, Anna Solini, Emanuela Orsi, et al.
Diabetes & Metabolism|December 2, 2022
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetesEmanuela Orsi, Anna Solini, Enzo Bonora, et al.
Cardiovascular Diabetology|December 2, 2022
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetesEmanuela Orsi, Anna Solini, Giuseppe Penno, et al.
Pageof 18